共 178 条
[1]
Cleator S(2007)Triple-negative breast cancer: therapeutic options Lancet Oncol 8 235-244
[2]
Heller W(2007)The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes Clin Cancer Res 13 2329-2334
[3]
Coombes RC(2008)Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer J Clin Oncol 26 1275-1281
[4]
Carey LA(2015)Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer Clin Cancer Res 21 1688-1698
[5]
Dees EC(2011)Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies J Clin Invest 121 2750-2767
[6]
Sawyer L(2016)Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection PLoS One 11 e0157368-2442
[7]
Gatti L(2017)Molecular alterations in triple-negative breast cancer-the road to new treatment strategies Lancet 389 2430-23
[8]
Moore DT(2011)Deconstructing the molecular portraits of breast cancer Mol Oncol 5 5-728
[9]
Collichio F(2012)Cancer stem cells: current status and evolving complexities Cell Stem Cell 10 717-197
[10]
Liedtke C(2016)Current advances in biomarkers for targeted therapy in triple-negative breast cancer Breast Cancer (Dove Med Press) 8 183-930